Solventum Corp reported first quarter ended March 31, 2026 results: revenue $2,007 million, net income $13 million, EPS $0.07. Guidance reaffirmed.
“range EAGAN, Minn., May 5, 2026 – Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights • S ales of $2.0 billion decreased (3.0)% on a reported basis; an increase of 2.1% on an organic basis • G AAP diluted earnings per share of $0.07; adjusted diluted earnings per share of $1.48, a 10.6%”
M&A Transactions
Solventum Corp completed a disposition involving Thermo Fisher Scientific Inc. for approximately $4.0 billion (closed 2025-09-01).
“Solventum completed the sale of the Business to the Buyer in accordance with the terms of the Agreement. The cash consideration paid to Solventum at closing was approximately $4.0 billion, which is subject to further adjustments for closing cash and indebtedness, unpaid transaction expenses and working capital as set forth in the Agreement, as well as a payment to”
Earnings Releases
Solventum Corp reported the first quarter ended March 31, 2024 results: revenue $2.016 billion, EPS $1.37. Guidance reaffirmed.
“Reports First Quarter 2024 Financial Results and Capital Allocation Update • Completed spin-off from 3M and began trading on April 1, 2024 • Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% • GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS 1 of $2.08 • Generated $442 million of cash from operations; free cash flow 1 of $340 million”
Shirley A. Edwards was elected as Director at Solventum Corp.
“On April 12, 2024, the Board of Directors (the “Board”) of Solventum Corporation (the “Company”) elected Shirley A. Edwards to the Company’s Board, effective April 12, 2024.”
Governance Changes
Solventum Corp: Adoption of Corporate Governance Guidelines and Board of Directors Code of Business Conduct and Ethics.
“In connection with the Distribution, the Board adopted Corporate Governance Guidelines and a Board of Directors Code of Business Conduct and Ethics, effective as of the Effective Time.”
Governance Changes
Solventum Corp: Amended and restated Bylaws effective March 31, 2024 (effective 2024-03-31).
“immediately thereafter, amended and restated its Bylaws (the “Amended and Restated Bylaws”)”
Governance Changes
Solventum Corp: Amended and restated Certificate of Incorporation effective March 31, 2024 (effective 2024-03-31).
“Effective as of 3:30 a.m. Eastern Time on March 31, 2024, Solventum amended and restated its Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”)”
Material Agreements
Solventum Corp entered into Separation and Distribution Agreement and related agreements with 3M Company valued at Entry into multiple separation-related agreements including Separation and Distribution Agreement, T (effective 2024-03-31).
“On March 31, 2024, Solventum Corporation (“Solventum”) entered into several agreements with 3M Company (“3M”) in connection with the spin-off of 3M’s health care business (the “Separation”) through the pro rata distribution of 80.1% of the issued and outstanding shares of common stock, par value $0.01 per share, of Solventum to 3M’s stockholders of record as of the close of business on March 18, 2024 (the “Distribution”).”
Tammy Gomez was appointed as Chief Human Resources Officer at Solventum Corp.
“Tammy Gomez Chief Human Resources Officer”
Paul Harrington was appointed as Chief Supply Chain Officer at Solventum Corp.
“Paul Harrington Chief Supply Chain Officer”
Amy Landucci was appointed as Chief Information and Digital Officer at Solventum Corp.
“Amy Landucci Chief Information and Digital Officer”
Chris Barry was appointed as Executive Vice President and Group President, Medical Solutions at Solventum Corp.
“Chris Barry Executive Vice President and Group President, Medical Solutions”
Mary Wilcox was appointed as Senior Vice President, Controller and Chief Accounting Officer at Solventum Corp.
“Mary Wilcox Senior Vice President, Controller and Chief Accounting Officer”
Marcela Kirberger was appointed as Chief Legal Affairs Officer, Corporate Secretary at Solventum Corp.
Wayde McMillan was appointed as Chief Financial Officer at Solventum Corp.
“Wayde McMillan Chief Financial Officer”
Bryan Hanson was appointed as Chief Executive Officer at Solventum Corp.
“Bryan Hanson Chief Executive Officer”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.